2022
DOI: 10.1016/j.jep.2022.115624
|View full text |Cite
|
Sign up to set email alerts
|

Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 72 publications
0
5
0
Order By: Relevance
“…We successfully identified 17 active ingredients acting on the IL-17 signaling pathway and 21 working on the PI3K-Akt-NFκB signaling pathway, such as decursin and rosmarinic acid. It was reported that quercetin and luteolin could treat allergic asthma by acting as critical targets related to PI3K-Akt and IL-17 signaling pathways, which was also verified in vivo 58,59 . Decursin could improve inflammatory diseases by regulating multiple pathways, including the PI3K-Akt- NFκB signaling pathway 60 .…”
Section: Discussionmentioning
confidence: 79%
“…We successfully identified 17 active ingredients acting on the IL-17 signaling pathway and 21 working on the PI3K-Akt-NFκB signaling pathway, such as decursin and rosmarinic acid. It was reported that quercetin and luteolin could treat allergic asthma by acting as critical targets related to PI3K-Akt and IL-17 signaling pathways, which was also verified in vivo 58,59 . Decursin could improve inflammatory diseases by regulating multiple pathways, including the PI3K-Akt- NFκB signaling pathway 60 .…”
Section: Discussionmentioning
confidence: 79%
“…The binding energy between the compound molecule and the target protein was used to evaluate the stability of ligand‐bound conformation. Generally, the lower the value of binding energy is, the stronger the binding activity of compounds with proteins is 44 . The results showed that 32 components identified in the serum of rats treated with ZQD‐W but not identified in that treated with ZQD‐W‐P can well dock with the target protein (binding energy was less than −5.0 kcal/mol), and most of them exhibited strong binding affinity with the target (binding energy was less than −7.0 kcal/mol) (Table 3).…”
Section: Resultsmentioning
confidence: 99%
“…Generally, the lower the value of binding energy is, the stronger the binding activity of compounds with proteins is. 44 The results showed that 32 components identified in the serum of rats treated with ZQD-W but not identified in that treated with ZQD-W-P can well dock with the target protein (binding energy was less than À5.0 kcal/mol), and most of them exhibited strong binding affinity with the target (binding energy was less than À7.0 kcal/mol) (Table 3). These data suggested that these specifically absorbed components of ZQD-W may combine PIK3CD to relieve MPS.…”
Section: Molecular Docking Analysismentioning
confidence: 99%
“…However, because that research was only conducted in vitro, further testing in live animal models, as well as human cell or tissue samples, is needed [43]. Some researchers have used network pharmacology, molecular docking, and bioinformatics to elucidate some traditional drugs that are commonly used but whose pharmacological mechanisms of action are unknown, including Chuankezhi injection, ephedra, modified Guo Min decoction, Gerbera Piloselloides Herba, Qi-Wei-Du-Qi-Wan, Huanglong cough oral liquid, Hyssopus cuspidatus Boriss, conciliatory anti-allergic decoction, Cucumis sativus L., Ziziphus mauritiana Lam leaves, Zhisou San, and Vochysia divergens Pohl (popularly known as "Cambará") [44][45][46][47]. Together, those studies demonstrated that luteolin could reduce airway inflammation and increase Th2 in OVA-sensitized mice while also effectively reducing autophagy levels in the lungs of asthmatic mice.…”
Section: Asthmamentioning
confidence: 99%